BIOMAT Database Logo BIOMAT Database Logo

Oral misoprostol versus oxytocin in the management of the third stage of labour. 2006

Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Department of Obstetrics and Gynecology, Memorial University of Newfoundland, St. John's NL.

OBJECTIVE To compare the effects of oral misoprostol 800 mug with intramuscular oxytocin 10 IU in routine management of the third stage of labour. METHODS This randomized controlled trial was performed in a rural district hospital in Ghana, West Africa, and enrolled women in labour with anticipated vaginal delivery and no known medical contraindication to prostaglandin administration. Women were randomized to receive oral misoprostol 800 mug or intramuscular oxytocin 10 IU. Blood samples were taken to determine hemoglobin concentration before delivery and at 12 hours post partum. Treatment was administered at delivery of the anterior shoulder. The primary outcome was the change in hemoglobin concentration from before to after delivery. Secondary outcomes included other measures of blood loss and presumed medication side effects. RESULTS In total, 450 women were enrolled in the study. Their baseline characteristics were similar. There was no significant difference between the groups in the change in hemoglobin concentration (misoprostol 1.07 g/dL and oxytocin 1.00 g/dL). The only significant secondary outcomes were shivering (80.7% with misoprostol vs. 3.6% with oxytocin) and pyrexia (11.4% with misoprostol, none with oxytocin). CONCLUSIONS Routine use of oral misoprostol 800 microg appears to be as effective as 10 IU parenteral oxytocin in minimizing blood loss during the third stage of labour, as determined by change in hemoglobin concentration. Misoprostol appears to be a safe, inexpensive, and effective uterotonic for use in rural and remote areas, where intravenous oxytocin may be unavailable.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007749 Labor Stage, Third The final period of OBSTETRIC LABOR that is from the expulsion of the FETUS to the expulsion of the PLACENTA. Labor, Third Stage,Labor Stages, Third,Stage, Third Labor,Stages, Third Labor,Third Labor Stage,Third Labor Stages,Third Stage Labor
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana

Related Publications

Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Oral misoprostol versus oxytocin in the management of third stage of labour.
April 2014, JPMA. The Journal of the Pakistan Medical Association,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.
March 2010, Singapore medical journal,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour.
January 2003, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Misoprostol versus oxytocin in the third stage of labor.
December 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
A randomized controlled study comparing oral misoprostol with intramuscular oxytocin in active management of third stage of labour.
May 2024, Obstetrics & gynecology science,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management.
February 2002, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Misoprostol and oxytocin versus oxytocin alone in the active management of the third stage of labour: a randomised, double-blind, placebo-controlled trial.
July 2022, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.
January 2004, The Cochrane database of systematic reviews,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Abu Dhabi third stage trial: oxytocin versus Syntometrine in the active management of the third stage of labour.
February 1995, European journal of obstetrics, gynecology, and reproductive biology,
Steven M Parsons, and Robert L Walley, and Joan M G Crane, and Kay Matthews, and Donna Hutchens
Misoprostol for third stage of labour.
May 1996, Lancet (London, England),
Copied contents to your clipboard!